The institutional investor held 113,650 shares of the major pharmaceuticals company at the end of 2017Q3, valued at $7.24M, up from 7,650 at the end of the previous reported quarter. Moreover, Ims Cap Management has 0.92% invested in Bristol-Myers Squibb Company (NYSE:BMY) for 22,399 shares.
Bristol-Myers Squibb (NYSE BMY) traded down $0.37 during midday trading on Monday, hitting $67.55. Lynch sold 5,300 shares of Bristol-Myers Squibb stock in a transaction on Tuesday, December 12th.
Bristol-Myers Squibb (NYSE:BMY) last announced its earnings results on Monday, February 5th. It has underperformed by 39.89% the S&P500.
Asa Gold & Precious Metals Ltd increased its stake in Eldorado Gold Corp (EGO) by 137.93% based on its latest 2017Q3 regulatory filing with the SEC. Sterling Capital Mngmt Ltd Liability Com holds 0.59% or 980,911 shares. The biopharmaceutical company reported $0.68 earnings per share for the quarter, topping the Zacks' consensus estimate of $0.67 by $0.01. About 536,823 shares traded. Cummins Inc. (NYSE:CMI) has risen 43.32% since March 12, 2017 and is uptrending. It has outperformed by 47.84% the S&P500. Timessquare Capital Ltd Limited Liability Company owns 0.54% invested in Marvell Technology Group Ltd. (NASDAQ:MRVL) for 4.49M shares. Cowen & Co maintained the shares of ABBV in report on Tuesday, September 5 with "Hold" rating. Therefore 100% are positive. QTS Realty Trust had 61 analyst reports since July 28, 2015 according to SRatingsIntel. The ex-dividend date is Thursday, April 5th. Zacks Investment Research cut Bristol-Myers Squibb from a "hold" rating to a "sell" rating in a research report on Tuesday, January 9th. As per Wednesday, April 6, the company rating was initiated by Societe Generale. On Thursday, October 26 the stock rating was maintained by Piper Jaffray with "Hold". The stock of AbbVie Inc. (NYSE:GS) earned "Neutral" rating by Buckingham Research on Wednesday, October 18. Leerink Swann maintained the stock with "Buy" rating in Thursday, July 27 report. The company was maintained on Thursday, July 30 by Goldman Sachs.More news: Sevilla boss Vincenzo Montella reveals Champions League tactics
Since October 18, 2017, it had 0 insider purchases, and 10 insider sales for $31.19 million activity. New York State Common Retirement Fund has 1.01 million shares. $705,655 worth of AbbVie Inc. (NASDAQ:FB) was sold by Cox Christopher K on Thursday, September 21. Patterson Uti Energy Inc now has $4.38B valuation. The shares were sold at an average price of $63.24, for a total transaction of $335,172.00.
Investors sentiment increased to 0.99 in 2017 Q3.
The company's Average Earnings Estimate for the Current Fiscal quarter is $0.84, according to consensus of 15 analysts. Chatham Incorporated invested in 0.13% or 7,445 shares. 128 funds opened positions while 644 raised stakes. Compton Cap Management Ri accumulated 1.09% or 38,012 shares. Deutsche Commercial Bank Ag holds 0.01% or 314,931 shares in its portfolio. Gradient Investments Ltd Liability Corporation accumulated 8,312 shares. Willingdon Wealth Mngmt reported 66,293 shares or 1.54% of all its holdings. Hills National Bank reported 14,750 shares stake. 19,375 are held by Reliant Inv Mgmt. Primecap Ca reported 6.37M shares. Fagan Assoc reported 4.97% stake. Cue Fin Group reported 0.58% of its portfolio in AbbVie Inc.
Beck Mack & Oliver Llc decreased Enstar Group Ltd (NASDAQ:ESGR) stake by 16,456 shares to 780,836 valued at $173.62M in 2017Q3. Trustmark Bank & Trust Trust Department stated it has 0.23% of its portfolio in Facebook, Inc. Three investment analysts have rated the stock with a sell rating, eleven have given a hold rating and eight have assigned a buy rating to the company. Therefore 33% are positive. Jefferies Group set a $72.00 price objective on Bristol-Myers Squibb and gave the company a "hold" rating in a report on Monday, February 26th. The firm earned "Underweight" rating on Monday, August 24 by Piper Jaffray. BMO Capital Markets maintained the shares of BMY in report on Tuesday, February 6 with "Underperform" rating. Bristol-Myers Squibb Company (NYSE:BMY) has noticeable measure of stock volatility, for this average true range is an exponential moving average (14 trading days) of the True Ranges. The rating was initiated by Hilliard Lyons with "Neutral" on Monday, May 23. (NYSE:QTS) rating on Monday, October 16. On Wednesday, August 23 the stock rating was maintained by Jefferies with "Buy". As per Friday, October 28, the company rating was maintained by Deutsche Bank. The firm has "Hold" rating given on Monday, February 5 by Stifel Nicolaus. Jennison Associates LLC now owns 26,854,242 shares of the biopharmaceutical company's stock worth $1,711,689,000 after acquiring an additional 3,735,453 shares during the last quarter. Prelude Cap Ltd Liability owns 0.13% invested in Bristol-Myers Squibb Company (NYSE:BMY) for 21,985 shares.More news: Taro Daniel took advantage of Novak Djokovic not being at his best
Since December 12, 2017, it had 1 buying transaction, and 1 sale for $85,985 activity. Shares for $249,187 were bought by Samuels Theodore R. II on Friday, December 15.
Investors sentiment decreased to 0.94 in Q3 2017. Its down 0.05, from 0.85 in 2017Q2. It increased, as 62 investors sold BMY shares while 519 reduced holdings. Hourglass Lc invested in 3.18% or 56,271 shares. Waldron Lp invested 0.07% in Bristol-Myers Squibb Company (NYSE:BMY). 35,000 are owned by Taconic Capital L P. Alphamark Advisors Llc reported 0.02% in Bristol-Myers Squibb Company (NYSE:BMY). Bristol-Myers Squibb comprises about 0.6% of Bollard Group LLC's investment portfolio, making the stock its 23rd largest position. C Ww Grp Holding A S has invested 0.23% of its portfolio in Bristol-Myers Squibb Company (NYSE:BMY).
Bristol-Myers Squibb Company is engaged in the discovery, development, licensing, manufacturing, marketing, distribution and sale of biopharmaceutical products. Mason Street Advsr Lc stated it has 227,652 shares. The institutional investor owned 74,070 shares of the biopharmaceutical company's stock after selling 2,628 shares during the quarter. Livforsakringsbolaget Skandia Omsesidigt stated it has 56,206 shares. Carroll Assoc Inc, a North Carolina-based fund reported 20,543 shares. Chilton Investment Co. LLC raised its stake in Bristol-Myers Squibb by 0.5% in the 2nd quarter. Accuvest Advsrs has invested 0% of its portfolio in Bristol-Myers Squibb Company (NYSE:BMY).
Chesley Taft & Associates Llc, which manages about $1.37 billion and $1.16B US Long portfolio, decreased its stake in Philip Morris International I (NYSE:PM) by 5,020 shares to 81,042 shares, valued at $9.00M in 2017Q3, according to the filing. It fall, as 40 investors sold PTEN shares while 64 reduced holdings.More news: Slingshot malware attacks PCs through routers